cas 167271-60-5|| where to buy (1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate

Nombre del producto:(1R,8S)-8-Amino-4-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-7-ox o-2-thiabicyclo[4.2.0]oct-4-ene-5-carboxylate

IUPAC Name:1-{[(1R,8S)-8-amino-5-carboxylato-7-oxo-2-thiabicyclo[4.2.0]oct-4-en-4-yl]methyl}imidazo[1,2-b]pyridazin-1-ium

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 167271-60-5 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :167271-60-5; Fórmula molecular:C15H14N4O3S; Punto de fusión:-; Código de sonrisas:N[C@@H]1[C@@H]2SCC(C[N+]3=C4C=CC=NN4C=C3)=C(C2C1=O)C([O-])=O; Densidad:

: Número de catálogo:CM574881; Peso molecular:330.36; Punto de ebullición:; Nº Mdl:MFCD15071650; Almacenamiento:

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

: Imidazopyridazines; Potent IRAK-4 inhibitors have been reported by several groups including some structurally related benzimidazoles as well as alternative fused heterocycles such as the imidazopyridine and imidazopyridazine. Such compounds are reported to have IRAK-1 and IRAK-4 activity with varying degrees of selectivity.